SCHEMBL24309684

SCHEMBL24309684

CC(C)c1ccccc1-c1cc(Oc2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)nc(NSc2cccc(N)c2)n1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 2/20 0.34
▸ CTSC P53634 5/20 0.34
▸ RAF1 P04049 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ JAK2 O60674 3/20 0.33
▸ JAK3 P52333 3/20 0.33
▸ PTK2 Q05397 3/20 0.33
▸ SOS1 Q07889 3/20 0.33
▸ ADRA2C P18825 1/20 0.32
▸ MAPK13 O15264 1/20 0.32
▸ MAPK12 P53778 1/20 0.32
▸ MAPK11 Q15759 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ HTR7 P34969 1/20 0.32
▸ HTR1A P08908 1/20 0.31
▸ EGFR P00533 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566585 0.85 HTR2C (0.42) METRAF1BRAFJAK2JAK3
SCHEMBL24309506 0.85 HTR2C (0.42) METRAF1BRAFJAK2JAK3
SCHEMBL24310457 0.83 BRD4 (0.39) PTK2ADRA2CEGFR
SCHEMBL24309467 0.83 EGFR (0.37) ADRA2CEGFR
SCHEMBL24310296 0.82 SOS1 (0.35) SOS1
SCHEMBL24309230 0.80 EGFR (0.32) JAK2HTR2AHTR7HTR1AEGFR
SCHEMBL24309593 0.80 KDM4E (0.33) JAK2HTR2AHTR7HTR1AEGFR
SCHEMBL24309736 0.79 CDK2 (0.32) —
SCHEMBL24310447 0.77 USP1 (0.33) JAK2JAK3
SCHEMBL24310509 0.77 CDK2 (0.32) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback